全文获取类型
收费全文 | 8372篇 |
免费 | 493篇 |
国内免费 | 113篇 |
专业分类
耳鼻咽喉 | 126篇 |
儿科学 | 84篇 |
妇产科学 | 100篇 |
基础医学 | 1362篇 |
口腔科学 | 176篇 |
临床医学 | 659篇 |
内科学 | 1592篇 |
皮肤病学 | 189篇 |
神经病学 | 630篇 |
特种医学 | 734篇 |
外科学 | 1168篇 |
综合类 | 34篇 |
预防医学 | 212篇 |
眼科学 | 249篇 |
药学 | 853篇 |
中国医学 | 112篇 |
肿瘤学 | 698篇 |
出版年
2023年 | 52篇 |
2022年 | 150篇 |
2021年 | 251篇 |
2020年 | 109篇 |
2019年 | 207篇 |
2018年 | 242篇 |
2017年 | 196篇 |
2016年 | 281篇 |
2015年 | 442篇 |
2014年 | 530篇 |
2013年 | 568篇 |
2012年 | 758篇 |
2011年 | 765篇 |
2010年 | 495篇 |
2009年 | 426篇 |
2008年 | 566篇 |
2007年 | 528篇 |
2006年 | 446篇 |
2005年 | 405篇 |
2004年 | 366篇 |
2003年 | 280篇 |
2002年 | 254篇 |
2001年 | 73篇 |
2000年 | 90篇 |
1999年 | 71篇 |
1998年 | 41篇 |
1997年 | 41篇 |
1996年 | 41篇 |
1995年 | 15篇 |
1994年 | 19篇 |
1993年 | 8篇 |
1992年 | 16篇 |
1991年 | 25篇 |
1990年 | 21篇 |
1989年 | 17篇 |
1988年 | 17篇 |
1987年 | 17篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 10篇 |
1983年 | 8篇 |
1981年 | 9篇 |
1980年 | 6篇 |
1979年 | 14篇 |
1978年 | 8篇 |
1975年 | 6篇 |
1974年 | 5篇 |
1973年 | 4篇 |
1962年 | 4篇 |
1961年 | 4篇 |
排序方式: 共有8978条查询结果,搜索用时 15 毫秒
61.
Hwan Bae Lee Jong Hwan Kwak Ok Pyo Zee Seung Jo Yoo 《Archives of pharmacal research》1994,17(4):273-277
Six flavonoids were isolated from the aerial parts ofCirsium rhinoceros. The flavonoids were identified as apigenin, luteolin, pectolinarigenin-7-O-β-D-glucopyranoside, linarin, pectolinarin and hispidulin-7-O-α-L-rhamnopyranosyl-(1→2)-β-D-glucopyranoside on the basis of chemical and spectral evidence. 相似文献
62.
Kwak JY Beer AE Kim SH Mantouvalos HP 《American journal of reproductive immunology (New York, N.Y. : 1989)》1999,41(1):91-98
PROBLEM: Placental lesions of 71 women with documented recurrent spontaneous abortions of unknown etiology were evaluated using immunohistochemical staining. METHOD OF STUDY: Placental tissue blocks (less than 12 weeks gestation) from prior pregnancy losses were obtained, recut, and analyzed utilizing monoclonal antibody to identify the trophoblast (cytokeratin 8/18) and natural killer (NK) cells (CD57) at the implantation site. The following features were evaluated: trophoblast invasion pattern; syncytium formation; vasculitis and thromboembolism of decidual vessels; decidual inflammation; decidual necrosis; fibrin deposition at the decidual necrosis site; mononuclear-cell infiltration in villi and intervillous space; perivillous fibrin deposition; trophoblast morphology; and quantitation of CD57+ NK cells within the decidual tissue near the implantation site. Controls consisted of 20 healthy women with no history of recurrent pregnancy losses, who had their pregnancies electively terminated. RESULTS: Of the women studied, 29.6% demonstrated elevated CD57+ NK cells at the implantation site (P = 0.030), 54.1% had inadequate cytotrophoblast invasion depth (P = 0.000), 44.1% demonstrated inadequate syncytium formation (P = 0.004), and 33.9% presented thromboembolism in decidual vessels (P = 0.025). CONCLUSION: Some women with recurrent spontaneous abortions demonstrate abnormal placental lesions at the implantation site. Immunopathologic evaluation of the placental implantation site that terminated in a spontaneous abortion may reveal the immunopathogenesis of previous pregnancy losses. 相似文献
63.
64.
Cytotoxicity of urushiols isolated from sap of Korean lacquer tree (Rhus vernicifera stokes) 总被引:1,自引:0,他引:1
Hong DH Han SB Lee CW Park SH Jeon YJ Kim MJ Kwak SS Kim HM 《Archives of pharmacal research》1999,22(6):638-641
Cytotoxicities of four urushiols, congeners isolated from the sap of Korean lacquer tree (Rhus vernicifera Stokes), to 29 human cancer cell lines originated from 9 organs were evaluated. Their values of 50% growth inhibition were below 4 microg/ml, and showed cell line specific cytotoxicity. The present result is the first report on the cytotoxicity of urushiols suggesting that they would have an anticancer activity to human cancer cells. 相似文献
65.
The extracts of sixty Korean plants were evaluated for their biological activities such as antitumor activities against Sarcoma 180, Leukemia SN-36 and Ehrlich ascites carcinoma, antimicrobial activities and behavioral observation in mice. The results are tabulated. 相似文献
66.
67.
Matthias Grube Katayoun Rezvani Adrian Wiestner Hiroshi Fujiwara Giuseppe Sconocchia Jan J Melenhorst Nancy Hensel Gerald E Marti Larry W Kwak Wyndham Wilson John A Barrett 《Clinical cancer research》2004,10(3):1047-1056
PURPOSE: To investigate potential immunotherapeutic strategies in B lymphocytic malignancies we looked for CTLs recognizing CD19 and CD20 epitopes. EXPERIMENTAL DESIGN: Three CD19 and CD20 peptides binding to HLA-A*0201 were identified and used to detect peptide specific CTLs by a quantitative real-time PCR to measure IFN-gamma mRNA expression in 23 healthy individuals and 28 patients (18 chronic lymphocytic leukemia (CLL), 7 follicular lymphoma, 2 acute lymphocytic leukemia, and 1 large cell lymphoma). Peptide-specific CTLs were expanded in culture with CD40-activated B cells to test lytic activity in three patients. RESULTS: In healthy individuals, CD8+ T-cell responses were detected in one to CD19(74-82), in three to CD20(127-135), and three to CD20(188-196). Seven of 27 patients (6 with CLL) had CD8+ T cells recognizing CD19(74-82). Seven patients responded to CD20(127-135) and three to CD20(188-196). All were CLL patients. CD19(74-82)-specific CTLs from three patients were expanded over 4 weeks. These cells were HLA-A*0201 specific and lytic for peptide-loaded antigen-presenting cells but not to malignant or unpulsed B cells. CONCLUSIONS: CTLs that recognize CD19 and CD20 epitopes exist in healthy individuals and may be increased in CLL patients. They are of low avidity and require high doses of peptide for activation. Strategies to increase T-cell avidity would be necessary for T-cell immunotherapeutic approaches using the peptides studied. 相似文献
68.
Sattva S Neelapu Sivasubramanian Baskar Barry L Gause Carol B Kobrin Thelma M Watson Andrea Robin Frye Robin Pennington Linda Harvey Elaine S Jaffe Richard J Robb Mircea C Popescu Larry W Kwak 《Clinical cancer research》2004,10(24):8309-8317
PURPOSE: The idiotype (Id) of the immunoglobulin on a given B-cell malignancy is a clonal marker that can serve as a tumor-specific antigen. We developed a novel vaccine formulation by incorporating Id protein with liposomal lymphokine that was more potent than a prototype, carrier-conjugated Id protein vaccine in preclinical studies. In the present study, we evaluated the safety and immunogenicity of this vaccine in follicular lymphoma patients. EXPERIMENTAL DESIGN: Ten patients with advanced-stage follicular lymphoma were treated with five doses of this second generation vaccine after chemotherapy-induced clinical remission. All patients were evaluated for cellular and humoral immune responses. RESULTS: Autologous tumor and Id-specific type I cytokine responses were induced by vaccination in 10 and 9 patients, respectively. Antitumor immune responses were mediated by both CD4+ and CD8+ T cells, were human lymphocyte antigen class I and II associated, and persisted 18 months beyond the completion of vaccination. Specific anti-Id antibody responses were detected in four patients. After a median follow-up of 50 months, 6 of the 10 patients remain in continuous first complete remission. CONCLUSIONS: This first clinical report of a liposomal cancer vaccine demonstrates that liposomal delivery is safe, induces sustained tumor-specific CD4+ and CD8+ T-cell responses in lymphoma patients, and may serve as a model for vaccine development against other human cancers and infectious pathogens. 相似文献
69.
Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors. 总被引:16,自引:0,他引:16
Tae Won Kim Hyoungnam Lee Yoon-Koo Kang Mi Sun Choe Min-Hee Ryu Heung Moon Chang Jung Sun Kim Jeong Hwan Yook Byung Sik Kim Jung Shin Lee 《Clinical cancer research》2004,10(9):3076-3081
PURPOSE: Constitutive mutational activation of c-kit has been found to be associated with the pathogenesis of gastrointestinal stromal tumors (GISTs). The prognostic significance of c-kit mutations, however, is still controversial. EXPERIMENTAL DESIGN: We examined 86 patients curatively resected for localized GIST. Genomic DNA was extracted from paraffin-embedded tumor tissues. Exons 9, 11, 13, and 17 of the c-kit gene were amplified by PCR and sequenced. RESULTS: Mutations in exon 11 were detected in 61 tumors, and mutations in exon 9 were observed in three tumors, whereas no mutations were detected in exons 13 or 17. The overall c-kit mutation frequency was 74%. Amino acid alterations in the 61 tumors with exon 11 mutations were deletion in 33 tumors, substitution in 20, both deletion and substitution in 4, insertion in 1, and duplication in 3. Histologically, tumors with c-kit mutations showed higher mitotic counts and higher cellularity. The 5-year relapse-free survival (RFS) in patients having GISTs with c-kit mutations was 21%, compared with 60% in those without c-kit mutations. Significantly higher RFS rates were observed in patients with tumors having mitotic counts < 5 mitoses/50 high power field, spindle-cell histology, tumor size < 5 cm, or gastric GISTs. Multivariate analyses indicated association of poorer RFS with a higher mitotic count > or = 5 of 50 high power fields; odds ratio (OR) = 3.0], presence of c-kit mutations (OR = 5.6), and a larger tumor size (> or = 5 cm; OR = 4.2). CONCLUSIONS: The presence of c-kit mutation, along with high mitotic count and larger tumor size, was an independent factor for poor prognosis in patients with localized GISTs. 相似文献
70.
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression 总被引:10,自引:0,他引:10
Sun Young Rha Joo Hang Kim Jae Kyung Roh Kyong Sik Lee Jin Sik Min Byung Soo Kim Hyun Cheol Chung 《Breast cancer research and treatment》1997,43(2):175-181
The degradation of the basement membrane by matrix-metalloproteinase(MMP) and serine protease is a critical pointin tumor invasion and metastasis. We measured theactivity of MMP-9 from 28 normal, 12 benignand 126 breast cancer tissues using gelatin zymographywith an image analysis system. ProMMP-9 was expressedin 17.5% of the cancer patients compared to2.5% in 40 non-cancerous tissues (p=0.014).The mature form of MMP-9 (82 kD) wasexpressed only in T2–T4 stages. During the earlyphase of breast cancer (DCIS and T1 stage)progression, only production of proMMP-9 increased. However, asthe cancer grew or invaded skin (T2–T4), orwith lymphovascular permeation, both production and activation ofMMP-9 increased. In conclusion, proMMP-9 production was themain cause of increased MMP-9 activity during theearly phase, while both production and activation increasedin the late phase of breast cancer. 相似文献